NL190237C - Amino-ethers en geneesmiddel dat deze amino-ethers bevat. - Google Patents

Amino-ethers en geneesmiddel dat deze amino-ethers bevat.

Info

Publication number
NL190237C
NL190237C NLAANVRAGE8003601,A NL8003601A NL190237C NL 190237 C NL190237 C NL 190237C NL 8003601 A NL8003601 A NL 8003601A NL 190237 C NL190237 C NL 190237C
Authority
NL
Netherlands
Prior art keywords
amino ethers
product containing
medicinal product
ethers
amino
Prior art date
Application number
NLAANVRAGE8003601,A
Other languages
English (en)
Dutch (nl)
Other versions
NL190237B (nl
NL8003601A (nl
Original Assignee
Jouveinal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jouveinal Sa filed Critical Jouveinal Sa
Publication of NL8003601A publication Critical patent/NL8003601A/nl
Publication of NL190237B publication Critical patent/NL190237B/xx
Application granted granted Critical
Publication of NL190237C publication Critical patent/NL190237C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
NLAANVRAGE8003601,A 1979-07-11 1980-06-21 Amino-ethers en geneesmiddel dat deze amino-ethers bevat. NL190237C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7917986 1979-07-11
FR7917986A FR2460919A1 (fr) 1979-07-11 1979-07-11 Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NL8003601A NL8003601A (nl) 1981-01-13
NL190237B NL190237B (nl) 1993-07-16
NL190237C true NL190237C (nl) 1993-12-16

Family

ID=9227765

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8003601,A NL190237C (nl) 1979-07-11 1980-06-21 Amino-ethers en geneesmiddel dat deze amino-ethers bevat.

Country Status (11)

Country Link
US (1) US4301163A (de)
JP (1) JPS5615250A (de)
BE (1) BE884212A (de)
CA (1) CA1148547A (de)
CH (1) CH644348A5 (de)
DE (1) DE3026201A1 (de)
ES (1) ES8103020A1 (de)
FR (1) FR2460919A1 (de)
GB (1) GB2054588B (de)
IT (1) IT1136190B (de)
NL (1) NL190237C (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE28069T1 (de) * 1982-09-07 1987-07-15 Ciba Geigy Ag Propylamin-derivate, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
US4824868A (en) * 1982-09-07 1989-04-25 Ciba-Geigy Corporation Propylamine derivatives useful for the treatment of dementia
US4692469A (en) * 1982-09-07 1987-09-08 Ciba-Geigy Corporation Propylamine derivatives
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
FR2643369B1 (fr) * 1989-02-20 1991-07-05 Jouveinal Sa La (+) 1-((3,4,5-trimethoxy) benzyloxymethyl)-1-phenyl-n,n-dimethyl-n-propylamine, son procede de preparation et son application en therapeutique
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
US5266599A (en) * 1989-02-20 1993-11-30 Jouveinal S.A. Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject
WO1993001169A2 (en) * 1991-07-05 1993-01-21 Merck Sharp & Dohme Limited Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
CA2110513A1 (en) * 1991-07-05 1993-01-21 Christopher J. Swain Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
WO1993001159A1 (en) * 1991-07-10 1993-01-21 Merck Sharp & Dohme Limited Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
ATE133658T1 (de) * 1991-07-10 1996-02-15 Merck Sharp & Dohme Aromatische verbindungen diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische verwendung
US5328927A (en) * 1992-03-03 1994-07-12 Merck Sharpe & Dohme, Ltd. Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
GB9211193D0 (en) * 1992-05-27 1992-07-08 Merck Sharp & Dohme Therapeutic agents
WO1994003429A1 (en) * 1992-07-31 1994-02-17 Merck Sharp & Dohme Limited Substituted amines as tachykinin receptor antagonists
DE69524962D1 (de) * 1994-08-22 2002-02-14 Welfide Corp Benzolderivate und deren medizinische verwendung
US5948820A (en) * 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
PT1471054E (pt) 2002-01-11 2009-09-23 Daiichi Sankyo Co Ltd Derivado de aminoálcool ou derivado de ácido fosfónico e composição medicinal que os contém
US20040010035A1 (en) * 2002-07-15 2004-01-15 Ciociola Arthur A. Gastrointestinal compositions
CA2491797A1 (en) * 2002-07-10 2004-01-22 Warner-Lambert Company Llc Gastrointestinal compositions
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
CA2491721A1 (en) * 2002-07-10 2004-01-22 Warner-Lambert Company Llc Gastrointestinal compositions comprising gaba derivatives
US7910617B2 (en) 2004-02-24 2011-03-22 Sankyo Company, Limited Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound
SE0400968D0 (sv) * 2004-04-14 2004-04-14 Astrazeneca Ab Aryl glycine ether derivatives and their use
US7666907B2 (en) * 2005-05-27 2010-02-23 Antibe Therapeutics Inc. Salts of trimebutine and N-desmethyl trimebutine
US7879913B2 (en) * 2005-06-28 2011-02-01 Catholic Healthcare West Iptakalim hydrochloride for decreasing nicotine use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2649445A (en) * 1948-02-28 1953-08-18 Bristol Lab Chloracetic acid ester of diphenyl ethanols
ES251290A1 (es) * 1958-08-21 1960-04-01 Parke Davis & Co Un procedimiento para la producciën de alcohilaminas arilsustituidas
GB1119835A (en) * 1964-07-20 1968-07-17 Analyses Et De Rech S Biolog M Process for the preparation of basic ethers
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4207343A (en) * 1978-06-22 1980-06-10 Eli Lilly And Company 1-Phenyl-3-(substituted phenoxy)propylamines

Also Published As

Publication number Publication date
ES493092A0 (es) 1981-02-16
GB2054588A (en) 1981-02-18
NL190237B (nl) 1993-07-16
IT1136190B (it) 1986-08-27
DE3026201C2 (de) 1990-11-08
US4301163A (en) 1981-11-17
JPS6253504B2 (de) 1987-11-10
IT8012595A0 (it) 1980-07-11
CH644348A5 (fr) 1984-07-31
JPS5615250A (en) 1981-02-14
FR2460919A1 (fr) 1981-01-30
NL8003601A (nl) 1981-01-13
DE3026201A1 (de) 1981-02-26
ES8103020A1 (es) 1981-02-16
CA1148547A (en) 1983-06-21
GB2054588B (en) 1983-06-29
BE884212A (fr) 1981-01-08
FR2460919B1 (de) 1983-11-10
US4301163B1 (de) 1990-01-23

Similar Documents

Publication Publication Date Title
NL190237C (nl) Amino-ethers en geneesmiddel dat deze amino-ethers bevat.
NO801863L (no) Farmasoeytiske preparater.
NL190552C (nl) 1-Fenyl-4-alkyl-7,8-dialkoxy-5H-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten.
NL182775C (nl) Corticosteroide bevattende farmaceutische preparaten.
GB2038812B (en) 1,2,4,5-tetra - alkyl - 4 - phenylpiperidines and pharmaceutical preparations thereof
DE2961804D1 (en) N-(3-benzoylpropyl)-spiro-(dihydrobenzofuranpiperidines and -pyrrolidines), derivatives thereof, methods for their preparation and their use for medicines
JPS5386038A (en) Pharmaceutical composition for animal and application
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
PH16131A (en) Phenyl quinolizidines,their pharmaceutical compositions and their use
DE2960506D1 (en) Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them
IT8026717A0 (it) Prodotto disinfestante eprocedimento per la sua preparazione.
SE8104236L (sv) 3-aminoproxifenylderivat, deras framstellning och lekemedel innehallande dessa
PH12590A (en) 4a-aryl octahydro-1h-2-pyrindines and pharmaceutical composition thereof
IL60733A (en) 1-substituted-pyrrolidinones,their manufacture and pharmaceutical compositions containing them
NO811003L (no) Farmasoeytiske preparater.
ZA815684B (en) Novel diaryl-imidazole compounds,processes for their manufacture,pharmaceutical preparations containing these compounds,and their use
DE3061280D1 (en) N,n-disubstituted-aminomethyl-phenylethanolamines and pharmaceutical formulations thereof
MY8500214A (en) Novel azathianaphthalene derivatives, process for their manufacture pharmaceutical preparations containing them and their use
ZA804038B (en) Aminothiadiazolyl compounds, processes for the manufacture thereof, and pharmaceutical preparations containing such compounds and the use thereof
NL182641C (nl) 3-amino-5-(4-pyridyl)-1,2,4-triazoolderivaten en deze derivaten bevattende farmaceutische preparaten.
NL930050I2 (nl) Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten.
IL61713A (en) 5-p-aminophenyl-2,2-dimethyl-4-phenyl-3-oxazolines,their manufacture and pharmaceutical compositions containing them
IL57885A0 (en) Oxadiazolotriazine derivatives,their manufacture and pharmaceutical compositions containing them
IL63661A0 (en) 4-carbamoyloxy-oxazaphosphorins,their production and pharmaceutical preparations containing them
NL7903540A (nl) Nieuwe anthracyclinen en farmaceutische preparaten, welke deze bevatten.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: JOUVEINAL S.A. TE PARIJS

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20000621